First author | DOP | Country | Period | Design | Mean of age | Type of ART | # of GDM in ART group | # of GDM in non-ART group | |||
---|---|---|---|---|---|---|---|---|---|---|---|
ART | Non-ART | n (GDM) | N (Total) | n (GDM) | N (Total) | ||||||
Varma TR [30] | 1987 | UK | 1983–1985 | Cohort | NA | NA | NA | 7 | 362 | 67 | 7284 |
Vollenhoven B [31] | 2000 | Australia | 1990–1997 | Case–Control | NA | NA | OI | 22 | 60 | 10 | 60 |
Bjercke S [32] | 2002 | Norway | 1993–1998 | Cohort | 31.32 | 32.7 | IVF | 4 | 52 | 2 | 355 |
Koivurova S [33] | 2002 | Finland | 1990–1995 | Cohort | 31.8 | 31.8 | IVF | 12 | 225 | 21 | 671 |
Nassar AH [34] | 2003 | USA | 1995–2000 | Cohort | 35 | 36 | IVF | 3 | 56 | 6 | 112 |
Pinborg A [35] | 2004 | Denmark | 1997 | Cohort | 33.1 | 30.5 | IVF/ICSI | 13 | 236 | 16 | 566 |
Shevell T [36] | 2005 | USA | 1999–2002 | Cohort | 33.19 | 29.9 | IVF/OI | 92 | 1776 | 1166 | 34,286 |
Saygan-Karamürsel B [21] | 2006 | Turkey | 1999–2003 | Case–Control | 31.45 | 28.94 | ICSI | 22 | 274 | 10 | 348 |
Buckett WM [37] | 2007 | Canada | 1998–2003 | Cohort | 34.375 | 34 | IVF/ICSI/IVM | 39 | 344 | 25 | 344 |
Adler-Levy Y [22] | 2007 | Israel | 1988–2002 | Case–Control | 30.27 | 29.4 | IVF/OI | 96 | 1036 | 153 | 3694 |
Eskandar M [38] | 2007 | Saudi Arabia | 2004–2006 | Cohort | 28.29 | 26.44 | ICSI | 3 | 35 | 7 | 73 |
Krieg SA [39] | 2008 | USA | 2001–2005 | Cohort | 42.7 | 41.3 | IVF | 10 | 71 | 9 | 108 |
Vasario E [40] | 2010 | Italy | 2004–2008 | Cohort | 31.5 | 33.5 | IVF | 10 | 84 | 13 | 139 |
Suzuki S [41] | 2010 | Japan | 2000–2007 | Cohort | 37.8 | 37.9 | IVF | 1 | 64 | 1 | 87 |
Tepper NK [42] | 2011 | USA | 1997–2004 | Cohort | 36 | 30 | NA | 112 | 6256 | 4434 | 595,168 |
Montoya JB [43] | 2012 | Mexico | 2005–2009 | Cohort | 32.5 | 31.6 | NA | 7 | 57 | 7 | 57 |
Moini A [44] | 2012 | Iran | 2008–2010 | Cohort | 30.6 | 27.3 | IVF/ICSI | 21 | 230 | 15 | 170 |
Bamberg C [45] | 2012 | Germany | 1998–2008 | Cohort | 32.5 | 30.1 | IVF/ICSI | 19 | 426 | 26 | 813 |
Le Ray C [46] | 2012 | France | 2008–2010 | Cohort | >43 | >43 | IVF/OD | 11 | 144 | 12 | 236 |
Werder E [47] | 2013 | USA | 2002–2008 | Cohort | NA | NA | IVF | 155 | 2233 | 30 | 299 |
Wang Y [48] | 2013 | Australia | 2007–2009 | Cross–Sectional | NA | NA | NA | 1044 | 13,732 | 19,333 | 386,660 |
Farhi A [49] | 2013 | Israel | 2006–2008 | Cohort |  |  | IVF/ICSI | 61 | 561 | 59 | 600 |
Toshimitsu M [50] | 2014 | Japan | 2006–2010 | Cohort | NA | NA | IVF/ICSI | 0 | 116 | 6 | 664 |
Castera D [51] | 2014 | Italy | 2007–2011 | Cohort | 38.5 | 33.5 | IVF/ICSI | 14 | 138 | 6 | 207 |
Ashrafi M [52] | 2014 | Iran | 2011–2012 | Cross–Sectional | 30 | 26.4 | IVF | 174 | 468 | 17 | 234 |
Ashrafi M [53] | 2014 | Iran | 2011–2012 | Cross–Sectional | 30.35 | 26.6 | ICSI/IVF/IUI | 13 | 54 | 4 | 20 |
Silberstein T [54] | 2014 | Israel | 1988–2006 | Cohort | 30.9 | 28.49 | IVF/OI | 492 | 3268 | 11,319 | 171,513 |
Yang X [55] | 2014 | China | 2011 | Cohort | NA | NA | ART | 172 | 1139 | 5179 | 111,264 |
Domingues A [56] | 2014 | Portugal | 1996–2011 | Cohort | NA | NA | IVF/ICSI | 15 | 180 | 31 | 698 |
Stern JE [57] | 2015 | USA | 2004–2008 | Cohort | NA | NA | NA | 81 | 3689 | 3363 | 302,085 |
Jie Z [58] | 2015 | China | 2010–2013 | Cohort | 32.53 | 29.87 |  | 48 | 428 | 190 | 2788 |
Nunes F [59] | 2015 | NA | NA | Case–Control | 34.3 | 31.4 | NA | 11 | 77 | 23 | 208 |
Barua S [60] | 2016 | Australia | 2007–2010 | Cohort | 32.1 | 29.2 | ART | 224 | 1727 | 3270 | 48,654 |
Zhu L [61] | 2016 | China | 2006–2014 | Cohort | 31.84 | 31.73 | IVF/ICSI | 309 | 2641 | 342 | 5282 |
Martin AS [62] | 2016 | USA | 2008–2012 | Cohort | NA | NA | ART | 397 | 14,761 | 22,925 | 100,857 |
Luke B [63] | 2016 | USA | 2004–2010 | Cohort | 36.65 | 30.1 | ART | 93 | 1338 | 2951 | 56,755 |
Bashmakova NV [64] | 2016 | Russia | NA | Cohort | NA | NA | ART | 12 | 37 | 6 | 96 |
Rosato E [65] | 2016 | Italy | 2010–2011 | Cohort | 44.2 | 44.1 | ART | 6 | 72 | 6 | 80 |
Valenzuela-lcaraz B [66] | 2016 | Spain | 2004–2010 | Cohort | 33.46 | 31 | IVF/ICSI/OI | 17 | 488 | 4 | 200 |
Marton V [67] | 2016 | Sweden | 1994–2014 | Cohort | 35.25 | 33.275 | IVF/ICSI | 54 | 312 | 44 | 912 |
Beyer DA [68] | 2016 | German | NA | Cohort | 39 | 39 | IVF/ICSI | 4 | 467 | 161 | 6417 |
Pourali L [69] | 2016 | Iran | 2009–2014 | Cohort | 28.9 | 27.1 | ART | 8 | 31 | 8 | 96 |
Ben-Yaakov RD [70] | 2016 | Israel | 1988–2012 | Cohort | 30.9 | 28.7 | IVF/OI | 585 | 4153 | 5895 | 95,138 |
Qin J [71] | 2016 | China | 2013–2016 | Cohort | 31.3 | 29.26 | IVF | 165 | 1260 | 823 | 4379 |
Wang YPA [72] | 2016 | Australia | 2007–2011 | Cohort | NA | NA | NA | 1736 | 21,615 | 30,869 | 574,905 |
Korosec S [73] | 2016 | Slovenia | 2004–2011 | Cohort | 33.42 | 33.42 | IVF/ET/FET | 43 | 1127 | 129 | 3381 |
Morency AM [74] | 2016 | Canada | 2000–2013 | Cohort | 33 | 31.4 | ART | 4 | 49 | 19 | 181 |
Luke B [75] | 2017 | USA | 2004–2010 | Cohort | 35.3 | 30.4 | IVF | 378 | 3538 | 493 | 6090 |